Lysko PG - Search Results

1

A comparison of carvedilol and metoprolol antioxidant activities in vitro.

Lysko PG, Webb CL, Gu JL, Ohlstein EH, Ruffolo RR Jr, Yue TL. Lysko PG, et al. J Cardiovasc Pharmacol. 2000 Aug;36(2):277-81. doi: 10.1097/00005344-200008000-00020. J Cardiovasc Pharmacol. 2000. PMID: 10942172

2

Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.

Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR Jr, Ohlstein EH, Ma XL, Yue TL. Gao F, et al. Eur J Pharmacol. 2000 Oct 6;406(1):109-16. doi: 10.1016/s0014-2999(00)00641-5. Eur J Pharmacol. 2000. PMID: 11011041

3

Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor.

Lysko PG, Lysko KA, Webb CL, Feuerstein G. Lysko PG, et al. Among authors: lysko ka. Neurosci Lett. 1992 Dec 14;148(1-2):34-8. doi: 10.1016/0304-3940(92)90798-c. Neurosci Lett. 1992. PMID: 1300500

4

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.

Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G. Yue TL, et al. Among authors: lysko pg, lysko ka. J Pharmacol Exp Ther. 1992 Oct;263(1):92-8. J Pharmacol Exp Ther. 1992. PMID: 1357162

5

Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.

Yue TL, McKenna PJ, Lysko PG, Ruffolo RR Jr, Feuerstein GZ. Yue TL, et al. Among authors: lysko pg. Atherosclerosis. 1992 Dec;97(2-3):209-16. doi: 10.1016/0021-9150(92)90133-2. Atherosclerosis. 1992. PMID: 1361324

6

Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein G. Lysko PG, et al. Among authors: lysko ka. Stroke. 1992 Nov;23(11):1630-5; discussion 1635-6. doi: 10.1161/01.str.23.11.1630. Stroke. 1992. PMID: 1440712

7

Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection.

Yue TL, Lysko PG, Barone FC, Gu JL, Ruffolo RR Jr, Feuerstein GZ. Yue TL, et al. Among authors: lysko pg. Ann N Y Acad Sci. 1994 Nov 17;738:230-42. doi: 10.1111/j.1749-6632.1994.tb21808.x. Ann N Y Acad Sci. 1994. PMID: 7832432 Review.

8

Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor.

Lysko PG, Webb CL, Feuerstein G. Lysko PG, et al. Neurosci Lett. 1994 Apr 25;171(1-2):77-80. doi: 10.1016/0304-3940(94)90609-2. Neurosci Lett. 1994. PMID: 7916141

9

SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.

Yue TL, Mckenna PJ, Lysko PG, Gu JL, Lysko KA, Ruffolo RR Jr, Feuerstein GZ. Yue TL, et al. Among authors: lysko pg, lysko ka. Eur J Pharmacol. 1994 Jan 14;251(2-3):237-43. doi: 10.1016/0014-2999(94)90405-7. Eur J Pharmacol. 1994. PMID: 8149979

10

Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions.

Lysko PG, Lysko KA, Webb CL, Feuerstein G, Mason PE, Walter MF, Mason RP. Lysko PG, et al. Among authors: lysko ka. Biochem Pharmacol. 1998 Dec 15;56(12):1645-56. doi: 10.1016/s0006-2952(98)00275-5. Biochem Pharmacol. 1998. PMID: 9973186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters